The Senior Scientist will join the Respiratory Biology Discovery group and contribute to target identification, target validation, translational biology, and mechanism-of-action studies supporting early discovery programs in chronic lung diseases, including COPD, bronchiectasis, asthma, pulmonary fibrosis, and inflammatory airway diseases. The successful candidate will leverage human-relevant in vitro, ex vivo, and translational experimental systems, with a particular emphasis on primary airway and alveolar epithelial biology, epithelial-stromal and immune-stromal interactions, tissue remodeling, fibrosis, regeneration, and biomarker discovery.